| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 419,890 | 367,800 | 326,558 | 435,373 | | Cost of Revenue | 354,039 | 313,353 | 287,383 | 371,648 | | | Gross Profit | 65,851 | 54,447 | 39,175 | 63,725 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 27,593 | 30,316 | 31,158 | 28,301 | | Non Recurring |
-
|
-
|
-
| 18,000 | | Others | 10,441 | 10,355 | 10,480 | 10,828 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 27,817 | 13,776 | (2,463) | 6,596 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (324) | 385 | 627 | 2,997 | | Earnings Before Interest And Taxes | 27,493 | 14,161 | (1,836) | 11,409 | | Interest Expense | 2,435 | 2,482 | 2,636 | 3,295 | | Income Before Tax | 25,058 | 11,679 | (4,472) | 8,114 | | Income Tax Expense | 6,246 | 5,512 | (1,962) | 340 | | Minority Interest | (146) | (121) |
-
| 1,816 | | | | Net Income From Continuing Ops | 18,666 | 6,046 | (2,510) | 7,774 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 18,666 | 6,046 | (2,510) | 7,774 | | Preferred Stock And Other Adjustments |
-
| (18) | 18 |
-
| | | Net Income Applicable To Common Shares | $18,666 | $6,028 | ($2,492) | $7,774 |
|
0.02% Nasdaq 
Income Statement
